Brought to you by 
Cortex licenses patent rights from University of California
13 Jul 1999
Executive Summary
Cortex Pharmaceuticals (drug therapies for neurological and psychiatric disorders) exclusively licensed additional patent rights from the University of California, increasing its commercial rights to potential treatments to schizophrenia.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cortex licenses patent rights from University of California
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice